Johnson & Johnson (JNJ)

USD 154.52

(-0.55%)

Inventory Summary of Johnson & Johnson

  • Johnson & Johnson's latest annual inventory in 2023 was 11.18 Billion USD , up 8.89% from previous year.
  • Johnson & Johnson's latest quarterly inventory in 2024 Q3 was 12.6 Billion USD , up 3.57% from previous quarter.
  • Johnson & Johnson reported annual inventory of 10.26 Billion USD in 2022, down -1.15% from previous year.
  • Johnson & Johnson reported annual inventory of 10.38 Billion USD in 2021, up 11.16% from previous year.
  • Johnson & Johnson reported quarterly inventory of 11.38 Billion USD for 2024 Q1, up 1.81% from previous quarter.
  • Johnson & Johnson reported quarterly inventory of 12.16 Billion USD for 2024 Q2, up 6.91% from previous quarter.

Annual Inventory Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Inventory of Johnson & Johnson (2023 - 1989)

Year Inventory Inventory Growth
2023 11.18 Billion USD 8.89%
2022 10.26 Billion USD -1.15%
2021 10.38 Billion USD 11.16%
2020 9.34 Billion USD 3.59%
2019 9.02 Billion USD 4.9%
2018 8.59 Billion USD -1.89%
2017 8.76 Billion USD 7.63%
2016 8.14 Billion USD 1.13%
2015 8.05 Billion USD -1.6%
2014 8.18 Billion USD 3.88%
2013 7.87 Billion USD 5.11%
2012 7.49 Billion USD 19.25%
2011 6.28 Billion USD 16.87%
2010 5.37 Billion USD 3.82%
2009 5.18 Billion USD 2.53%
2008 5.05 Billion USD -1.14%
2007 5.11 Billion USD 4.52%
2006 4.88 Billion USD 23.49%
2005 3.95 Billion USD 5.74%
2004 3.74 Billion USD 4.35%
2003 3.58 Billion USD 8.63%
2002 3.3 Billion USD 10.39%
2001 2.99 Billion USD 5.28%
2000 2.84 Billion USD -8.17%
1999 3.09 Billion USD 8.48%
1998 2.85 Billion USD 13.39%
1997 2.51 Billion USD 0.72%
1996 2.49 Billion USD 9.75%
1995 2.27 Billion USD 5.32%
1994 2.16 Billion USD 25.86%
1993 1.71 Billion USD -1.44%
1992 1.74 Billion USD 2.35%
1991 1.7 Billion USD 10.3%
1990 1.54 Billion USD 14.04%
1989 1.35 Billion USD 6.28%

Peer Inventory Comparison of Johnson & Johnson

Name Inventory Inventory Difference
AbbVie Inc. 4.09 Billion USD -172.774%
Bristol-Myers Squibb Company 2.66 Billion USD -320.023%
Bristol-Myers Squibb Company Ce 2.66 Billion USD -320.023%
Eli Lilly and Company 5.77 Billion USD -93.684%
Merck & Co., Inc. 6.35 Billion USD -75.857%
Novartis AG 5.91 Billion USD -89.092%
Organon & Co. 1.31 Billion USD -750.266%
Pfizer Inc. 10.18 Billion USD -9.736%